Currently out of the existing stock ratings of Joe Kim, 2 are a BUY (100%).

Joe Kim

Work Performance Price Targets & Ratings Chart

Analyst Joe Kim, currently employed at RBC, has had 50% of price targets met with an average potential upside of 38.84%, reached in 131 days on average.

Joe Kim has documented 4 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 26-Feb-2026.

Wall Street Analyst Joe Kim

Analyst best performing recommendations are on MIRM (MIRUM PHARMACEUTICALS).
The best stock recommendation documented was for MIRM (MIRUM PHARMACEUTICALS) on 2/26/2026. The price target of $128 was fulfilled within 131 days with a profit of $35.81 (38.84%), with a performance score of 2.97.

Average potential price target upside

MIRM Mirum Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Jun-2026

$194

$100.01 (106.40%)

$184

9 days ago
(11-Nov-2026)

0/4 (0%)

$99.58 (105.46%)

Buy Since 07-May-2026

$155

$61.01 (64.91%)

$155

16 days ago
(04-Nov-2026)

0/5 (0%)

$58.03 (59.84%)

Buy Since 19-May-2025

$202

$108.01 (114.92%)

$200

16 days ago
(04-Nov-2026)

4/12 (33.33%)

$105.03 (108.31%)

75

Buy Since 24-Oct-2023

$160

$66.01 (70.23%)

$140

16 days ago
(04-Nov-2026)

10/12 (83.33%)

$63.03 (65.00%)

243

Buy Since 20-Sep-2023

$167

$73.01 (77.68%)

$137

16 days ago
(04-Nov-2026)

15/26 (57.69%)

$70.03 (72.22%)

415

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Joe Kim?

On 2026
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?